Whitfield Advises Accel-KKR in Spinout of ECRI’s Healthcare Spend Management and Recall Management Solutions Business
Overview
ECRI's healthcare purchasing and product-recall operations were to become Staritas, an independent business backed by technology investor Accel-KKR, according to the source.
Business separation
The transaction involves a spinout of spend-management and recall-management services, preserving the new company's focus on healthcare supply-chain information.
Advisory scope
The announcement lists corporate, tax, intellectual-property, employment, finance, healthcare and government-contracts workstreams, reflecting the range of issues in the separation.
Named participants
Shelly Hirschtritt, John Wilkes, Jacob Reichman and Ryan Kidman are identified for corporate work, with Devin Heckman and Shiyu Ni listed for tax matters.
Related Pages
Whitfield Advises AEVEX on Acquisition of BlackSea TechnologiesWhitfield Advises Thrive Holdings on $2 Billion FundraiseWhitfield Represents Trinity Hunt Partners on Investment in Fisher Management PartnersBostonBrusselsChicago
View More (18)
DallasHoustonLos AngelesBay Area – San FranciscoWashington, D.C.Technology & IP TransactionsAntitrust & CompetitionGovernment ContractsDebt FinanceEmployee BenefitsEmployment & LaborExecutive CompensationHealthcare & Life Sciences TransactionsInternational Trade & National SecurityMergers & AcquisitionsPrivate EquityReal EstateTax
